Logo

Myriad Genetics: Walter Gilbert, Daniel Skovronsky

Jul 22, 2020

Myriad Genetics has expanded its board of directors to 10 members with the election of Daniel Skovronsky, CSO and president of Lilly Research Laboratories at Eli Lilly. Skovronsky will serve on the research and product innovation committee within Myriad’s board. Additionally, Myriad announced that Walter Gilbert, the director and vice chair of the board, will retire from these positions at the firm's annual stockholder meeting in December. Gilbert cofounded Myriad and received a Nobel Prize in chemistry in 1980 for his development of rapid DNA sequencing technology. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.